(1) This Policy aims: (2) The implementation of this Policy will comply with relevant legislation, promote high quality research and teaching and minimize risks to human and animal health and the environment. (3) HESF: Standards 2.3 Wellbeing and Safety; 4.1 Research; 4.2 Research Training; 5.2 Academic and Research Integrity. (4) This Policy applies across the University and to all University Staff, students, contractors, volunteers and visitors who: (5) This Policy does not apply to: (6) Biohazard: A biohazard is a potential source of harm caused by biological risk group agents or toxins. Biohazards, which may provoke infection, allergy or toxicity in humans, animals or plants include: (7) Biological agents: Any living organism that may cause harm to humans, animals or the environment. This includes pathogens; biological toxins; material of human or animal origin such as blood, body fluids, tissues, cells, cell lines, live animals; whole plants; plant material; environmental, food and other types of samples that have a potential for containing biological agents including pathogens; any other material of biological origin; and biological molecules such as DNA, RNA extracted from any of the samples listed above. (8) Biological Physical Containment: A system of confining microorganisms or other entities within a defined space. (9) Biosafety: Containment principles, technologies and practices that are implemented to prevent the unintentional exposure to biological agents or toxins, or their accidental release into the environment. (10) Dealing: A "dealing" with biologically hazardous material is defined as: (11) Defence and Strategic Goods List (DSGL): goods and technology of biosecurity concern that may not be exported from Australia unless a permit has been granted. (12) Genetically modified organism (GMO): An organism that has been modified by gene technology (a)*; or, (13) The Therapeutic Goods Administration (TGA): Part of the Australian Government Department of Health and Aged Care, and is responsible for regulating therapeutic goods including prescription medicines, vaccines, sunscreens, vitamins and minerals, medical devices, blood and blood products. (14) Security Sensitive Biological Agent (SSBA): A biological agent outlined and regulated by the National Health Security Act. (15) All staff and students working with biohazards at Victoria University (VU) must be aware of, and comply with, the requirements of all relevant legislation or regulations governing dealings with biohazards. A list of regulatory requirements can be found on the Compliance Website. (16) All those involved in activities with biologicals must ensure that biohazards are identified, together with planned actions to eliminate or, if this is not possible, mitigate the risks. The steps taken to identify biohazards and to eliminate risks must be recorded to establish credible data which enables measurement and improvement. (17) All staff are expected to take an active role in creating safe work places and work practices by complying with University policies and procedures, taking responsibility for their own actions, and not putting themselves or others at risk. (18) VU expects all those working with biologicals to: (19) Where appropriate, VU will: (20) VU will seek to ensure that: (21) Biosafety - Dealings Involving Risk Group Agents (22) Biosafety - Internal Certification of Containment Laboratories Procedure (23) Biosafety - Dealings Involving Genetically Modified Organisms Procedure (24) Biosafety - Importing and Exporting Biological Material Procedure (25) Biosafety - Non-Compliance & Adverse Incidents Procedure (26) Biosafety - Packaging and Transport of Biological Materials Procedure (27) Biosafety - Labelling, Storage and Transport of Genetically Modified Material Procedure (28) Compliance Website (29) VU Policy Library (30) Health and Safety - OHS Incident Reporting and Investigation Procedure (31) AS/NZS 2243.3 Microbiological Safety and Containment. Access to current document is restricted by limited VU Licence (32) Biosecurity Act 2015 (Cth) (33) Gene Technology Act 2000 (Cth) (34) Gene Technology Regulations 2001 (Cth) (35) Defence and Strategic Goods List 2021 (Cth) (36) TGA WebsiteBiosafety Policy
Section 1 - Summary
Section 2 - HESF/ASQA/ESOS Alignment
Section 3 - Scope
Top of PageSection 4 - Definitions
and includes:
an organism that has inherited traits from an organism, where the traits occurred in the initial organism because of gene technology; or, anything declared by the regulations to be a genetically modified organism, or that belongs to a class of things declared by the regulations to be genetically modified organisms; but does not include:
* The TGA will continue to monitor the conduct of human gene therapy especially if the work involves a live or viable GMO which may present possible occupational health and safety or environmental risks.Section 5 - Policy Statement
Part A - Compliance
Part B - Communication and Training
Part C - Quality, Standards & Risk Management
Top of Page
Section 6 - Procedures
Section 7 - Supporting Documents and Information
View Document
This is the current version of this document. To view historic versions, click on the 'Historic Versions' tab above.